TW472053B - Process for the synthesis of benzothiophenes - Google Patents
Process for the synthesis of benzothiophenes Download PDFInfo
- Publication number
- TW472053B TW472053B TW086113989A TW86113989A TW472053B TW 472053 B TW472053 B TW 472053B TW 086113989 A TW086113989 A TW 086113989A TW 86113989 A TW86113989 A TW 86113989A TW 472053 B TW472053 B TW 472053B
- Authority
- TW
- Taiwan
- Prior art keywords
- patent application
- formula
- item
- scope
- compound
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 35
- 230000008569 process Effects 0.000 title abstract description 7
- FCEHBMOGCRZNNI-UHFFFAOYSA-N 1-benzothiophene Chemical class C1=CC=C2SC=CC2=C1 FCEHBMOGCRZNNI-UHFFFAOYSA-N 0.000 title abstract 2
- 230000015572 biosynthetic process Effects 0.000 title description 7
- 238000003786 synthesis reaction Methods 0.000 title description 6
- 150000001875 compounds Chemical class 0.000 claims abstract description 28
- 239000003729 cation exchange resin Substances 0.000 claims abstract description 16
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 claims abstract description 15
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims abstract description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 67
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 claims description 34
- -1 hexahydropyridyl Chemical group 0.000 claims description 23
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 claims description 22
- 238000007363 ring formation reaction Methods 0.000 claims description 21
- 239000011347 resin Substances 0.000 claims description 20
- 229920005989 resin Polymers 0.000 claims description 20
- 238000011049 filling Methods 0.000 claims description 17
- 239000011541 reaction mixture Substances 0.000 claims description 11
- 229940098779 methanesulfonic acid Drugs 0.000 claims description 10
- 150000003839 salts Chemical class 0.000 claims description 10
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 9
- 230000002079 cooperative effect Effects 0.000 claims description 9
- 125000000217 alkyl group Chemical group 0.000 claims description 8
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 7
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 5
- 229910052757 nitrogen Inorganic materials 0.000 claims description 5
- 239000004793 Polystyrene Substances 0.000 claims description 3
- 229920002223 polystyrene Polymers 0.000 claims description 3
- 239000012453 solvate Substances 0.000 claims description 3
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 2
- 125000003554 tetrahydropyrrolyl group Chemical group 0.000 claims description 2
- 239000003456 ion exchange resin Substances 0.000 claims 1
- 229920003303 ion-exchange polymer Polymers 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 abstract description 4
- 229940023913 cation exchange resins Drugs 0.000 abstract description 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 2
- 238000006243 chemical reaction Methods 0.000 description 34
- 239000002904 solvent Substances 0.000 description 23
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 21
- 238000010520 demethylation reaction Methods 0.000 description 11
- 230000008707 rearrangement Effects 0.000 description 11
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 10
- 239000002253 acid Substances 0.000 description 10
- 230000017858 demethylation Effects 0.000 description 9
- KWOLFJPFCHCOCG-UHFFFAOYSA-N Acetophenone Chemical compound CC(=O)C1=CC=CC=C1 KWOLFJPFCHCOCG-UHFFFAOYSA-N 0.000 description 8
- 238000010992 reflux Methods 0.000 description 8
- 239000007858 starting material Substances 0.000 description 8
- 125000005605 benzo group Chemical group 0.000 description 7
- 238000001914 filtration Methods 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 125000004203 4-hydroxyphenyl group Chemical group [H]OC1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 239000003377 acid catalyst Substances 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 5
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 5
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 5
- 239000006227 byproduct Substances 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 239000003480 eluent Substances 0.000 description 5
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- 239000000758 substrate Substances 0.000 description 5
- 229930192474 thiophene Natural products 0.000 description 5
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- 150000007513 acids Chemical class 0.000 description 4
- ILAHWRKJUDSMFH-UHFFFAOYSA-N boron tribromide Chemical compound BrB(Br)Br ILAHWRKJUDSMFH-UHFFFAOYSA-N 0.000 description 4
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 4
- 239000003054 catalyst Substances 0.000 description 4
- 150000001768 cations Chemical class 0.000 description 4
- 229920001429 chelating resin Polymers 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 238000006462 rearrangement reaction Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- OXPDQFOKSZYEMJ-UHFFFAOYSA-N 2-phenylpyrimidine Chemical compound C1=CC=CC=C1C1=NC=CC=N1 OXPDQFOKSZYEMJ-UHFFFAOYSA-N 0.000 description 3
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- YNQLUTRBYVCPMQ-UHFFFAOYSA-N Ethylbenzene Chemical compound CCC1=CC=CC=C1 YNQLUTRBYVCPMQ-UHFFFAOYSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- 238000005481 NMR spectroscopy Methods 0.000 description 3
- 229920005654 Sephadex Polymers 0.000 description 3
- 239000012507 Sephadex™ Substances 0.000 description 3
- 229920002684 Sepharose Polymers 0.000 description 3
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 150000007522 mineralic acids Chemical class 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 239000011877 solvent mixture Substances 0.000 description 3
- 239000011701 zinc Substances 0.000 description 3
- 229910052725 zinc Inorganic materials 0.000 description 3
- 239000007848 Bronsted acid Substances 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 2
- 239000002841 Lewis acid Substances 0.000 description 2
- YNPNZTXNASCQKK-UHFFFAOYSA-N Phenanthrene Natural products C1=CC=C2C3=CC=CC=C3C=CC2=C1 YNPNZTXNASCQKK-UHFFFAOYSA-N 0.000 description 2
- DLRVVLDZNNYCBX-UHFFFAOYSA-N Polydextrose Polymers OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(O)O1 DLRVVLDZNNYCBX-UHFFFAOYSA-N 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- DGEZNRSVGBDHLK-UHFFFAOYSA-N [1,10]phenanthroline Chemical compound C1=CN=C2C3=NC=CC=C3C=CC2=C1 DGEZNRSVGBDHLK-UHFFFAOYSA-N 0.000 description 2
- 229960000583 acetic acid Drugs 0.000 description 2
- 235000011054 acetic acid Nutrition 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 239000003849 aromatic solvent Substances 0.000 description 2
- 238000010533 azeotropic distillation Methods 0.000 description 2
- 229940077388 benzenesulfonate Drugs 0.000 description 2
- SRSXLGNVWSONIS-UHFFFAOYSA-M benzenesulfonate Chemical compound [O-]S(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-M 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 238000005341 cation exchange Methods 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- 238000012937 correction Methods 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 238000000921 elemental analysis Methods 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 238000000434 field desorption mass spectrometry Methods 0.000 description 2
- 229940093915 gynecological organic acid Drugs 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- 150000007517 lewis acids Chemical class 0.000 description 2
- 238000011068 loading method Methods 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- 239000012044 organic layer Substances 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
- 229920000137 polyphosphoric acid Polymers 0.000 description 2
- 125000006239 protecting group Chemical group 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 229940095743 selective estrogen receptor modulator Drugs 0.000 description 2
- 239000000333 selective estrogen receptor modulator Substances 0.000 description 2
- 235000015170 shellfish Nutrition 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 150000003460 sulfonic acids Chemical class 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- UWYVPFMHMJIBHE-OWOJBTEDSA-N (e)-2-hydroxybut-2-enedioic acid Chemical compound OC(=O)\C=C(\O)C(O)=O UWYVPFMHMJIBHE-OWOJBTEDSA-N 0.000 description 1
- UIMPAOAAAYDUKQ-UHFFFAOYSA-N 1-methoxy-4-(4-methoxyphenyl)benzene Chemical compound C1=CC(OC)=CC=C1C1=CC=C(OC)C=C1 UIMPAOAAAYDUKQ-UHFFFAOYSA-N 0.000 description 1
- 229940015297 1-octanesulfonic acid Drugs 0.000 description 1
- BLXJAQAAGUYYLF-UHFFFAOYSA-N 1-phenoxy-9h-fluorene Chemical compound C=12CC3=CC=CC=C3C2=CC=CC=1OC1=CC=CC=C1 BLXJAQAAGUYYLF-UHFFFAOYSA-N 0.000 description 1
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 1
- HCSBTDBGTNZOAB-UHFFFAOYSA-N 2,3-dinitrobenzoic acid Chemical class OC(=O)C1=CC=CC([N+]([O-])=O)=C1[N+]([O-])=O HCSBTDBGTNZOAB-UHFFFAOYSA-N 0.000 description 1
- LBLYYCQCTBFVLH-UHFFFAOYSA-N 2-Methylbenzenesulfonic acid Chemical compound CC1=CC=CC=C1S(O)(=O)=O LBLYYCQCTBFVLH-UHFFFAOYSA-N 0.000 description 1
- SCVJRXQHFJXZFZ-KVQBGUIXSA-N 2-amino-9-[(2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-3h-purine-6-thione Chemical compound C1=2NC(N)=NC(=S)C=2N=CN1[C@H]1C[C@H](O)[C@@H](CO)O1 SCVJRXQHFJXZFZ-KVQBGUIXSA-N 0.000 description 1
- IKCLCGXPQILATA-UHFFFAOYSA-N 2-chlorobenzoic acid Chemical class OC(=O)C1=CC=CC=C1Cl IKCLCGXPQILATA-UHFFFAOYSA-N 0.000 description 1
- 125000003635 2-dimethylaminoethoxy group Chemical group [H]C([H])([H])N(C([H])([H])[H])C([H])([H])C([H])([H])O* 0.000 description 1
- WLVPRARCUSRDNI-UHFFFAOYSA-N 2-hydroxy-1-phenyl-1-propanone Chemical compound CC(O)C(=O)C1=CC=CC=C1 WLVPRARCUSRDNI-UHFFFAOYSA-N 0.000 description 1
- 125000005916 2-methylpentyl group Chemical group 0.000 description 1
- PJRGDKFLFAYRBV-UHFFFAOYSA-N 2-phenylthiophene Chemical compound C1=CSC(C=2C=CC=CC=2)=C1 PJRGDKFLFAYRBV-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- ZQVKTHRQIXSMGY-UHFFFAOYSA-N 4-Ethylbenzoic acid Chemical compound CCC1=CC=C(C(O)=O)C=C1 ZQVKTHRQIXSMGY-UHFFFAOYSA-N 0.000 description 1
- PXACTUVBBMDKRW-UHFFFAOYSA-N 4-bromobenzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=C(Br)C=C1 PXACTUVBBMDKRW-UHFFFAOYSA-N 0.000 description 1
- 125000004860 4-ethylphenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])C([H])([H])[H] 0.000 description 1
- OBKXEAXTFZPCHS-UHFFFAOYSA-N 4-phenylbutyric acid Chemical compound OC(=O)CCCC1=CC=CC=C1 OBKXEAXTFZPCHS-UHFFFAOYSA-N 0.000 description 1
- UHFMMKITEVHTLB-UHFFFAOYSA-N 9h-fluorene-2-sulfonic acid Chemical compound C1=CC=C2C3=CC=C(S(=O)(=O)O)C=C3CC2=C1 UHFMMKITEVHTLB-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- HKMTVMBEALTRRR-UHFFFAOYSA-N Benzo[a]fluorene Chemical compound C1=CC=CC2=C3CC4=CC=CC=C4C3=CC=C21 HKMTVMBEALTRRR-UHFFFAOYSA-N 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 1
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 241000283074 Equus asinus Species 0.000 description 1
- BDAGIHXWWSANSR-UHFFFAOYSA-M Formate Chemical compound [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 description 1
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- AEMRFAOFKBGASW-UHFFFAOYSA-M Glycolate Chemical compound OCC([O-])=O AEMRFAOFKBGASW-UHFFFAOYSA-M 0.000 description 1
- 150000000994 L-ascorbates Chemical class 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-L Malonate Chemical compound [O-]C(=O)CC([O-])=O OFOBLEOULBTSOW-UHFFFAOYSA-L 0.000 description 1
- QIAFMBKCNZACKA-UHFFFAOYSA-N N-benzoylglycine Chemical compound OC(=O)CNC(=O)C1=CC=CC=C1 QIAFMBKCNZACKA-UHFFFAOYSA-N 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-L Phosphate ion(2-) Chemical compound OP([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-L 0.000 description 1
- 229920001100 Polydextrose Polymers 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- PJANXHGTPQOBST-VAWYXSNFSA-N Stilbene Natural products C=1C=CC=CC=1/C=C/C1=CC=CC=C1 PJANXHGTPQOBST-VAWYXSNFSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- WAIPAZQMEIHHTJ-UHFFFAOYSA-N [Cr].[Co] Chemical compound [Cr].[Co] WAIPAZQMEIHHTJ-UHFFFAOYSA-N 0.000 description 1
- IPBVNPXQWQGGJP-UHFFFAOYSA-N acetic acid phenyl ester Natural products CC(=O)OC1=CC=CC=C1 IPBVNPXQWQGGJP-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 125000005036 alkoxyphenyl group Chemical group 0.000 description 1
- 159000000032 aromatic acids Chemical class 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 238000012550 audit Methods 0.000 description 1
- PXXJHWLDUBFPOL-UHFFFAOYSA-N benzamidine Chemical compound NC(=N)C1=CC=CC=C1 PXXJHWLDUBFPOL-UHFFFAOYSA-N 0.000 description 1
- MIAUJDCQDVWHEV-UHFFFAOYSA-N benzene-1,2-disulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1S(O)(=O)=O MIAUJDCQDVWHEV-UHFFFAOYSA-N 0.000 description 1
- WRUAHXANJKHFIL-UHFFFAOYSA-N benzene-1,3-disulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC(S(O)(=O)=O)=C1 WRUAHXANJKHFIL-UHFFFAOYSA-N 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 239000012965 benzophenone Substances 0.000 description 1
- 150000008366 benzophenones Chemical class 0.000 description 1
- NHOWLEZFTHYCTP-UHFFFAOYSA-N benzylhydrazine Chemical compound NNCC1=CC=CC=C1 NHOWLEZFTHYCTP-UHFFFAOYSA-N 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- 238000013124 brewing process Methods 0.000 description 1
- 125000001246 bromo group Chemical group Br* 0.000 description 1
- IAQRGUVFOMOMEM-UHFFFAOYSA-N but-2-ene Chemical group CC=CC IAQRGUVFOMOMEM-UHFFFAOYSA-N 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000020335 dealkylation Effects 0.000 description 1
- 238000006900 dealkylation reaction Methods 0.000 description 1
- 238000010511 deprotection reaction Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 150000001991 dicarboxylic acids Chemical class 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-M dihydrogenphosphate Chemical compound OP(O)([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-M 0.000 description 1
- IJKVHSBPTUYDLN-UHFFFAOYSA-N dihydroxy(oxo)silane Chemical compound O[Si](O)=O IJKVHSBPTUYDLN-UHFFFAOYSA-N 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 1
- 235000011180 diphosphates Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000011067 equilibration Methods 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000004992 fast atom bombardment mass spectroscopy Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000003818 flash chromatography Methods 0.000 description 1
- RMBPEFMHABBEKP-UHFFFAOYSA-N fluorene Chemical compound C1=CC=C2C3=C[CH]C=CC3=CC2=C1 RMBPEFMHABBEKP-UHFFFAOYSA-N 0.000 description 1
- 125000003983 fluorenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3CC12)* 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hcl hcl Chemical compound Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
- MNWFXJYAOYHMED-UHFFFAOYSA-N heptanoic acid Chemical class CCCCCCC(O)=O MNWFXJYAOYHMED-UHFFFAOYSA-N 0.000 description 1
- FYAQQULBLMNGAH-UHFFFAOYSA-N hexane-1-sulfonic acid Chemical compound CCCCCCS(O)(=O)=O FYAQQULBLMNGAH-UHFFFAOYSA-N 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-M hydrogensulfate Chemical compound OS([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-M 0.000 description 1
- 229940071870 hydroiodic acid Drugs 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000009878 intermolecular interaction Effects 0.000 description 1
- 238000003402 intramolecular cyclocondensation reaction Methods 0.000 description 1
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 1
- KQNPFQTWMSNSAP-UHFFFAOYSA-N isobutyric acid Chemical compound CC(C)C(O)=O KQNPFQTWMSNSAP-UHFFFAOYSA-N 0.000 description 1
- TWBYWOBDOCUKOW-UHFFFAOYSA-N isonicotinic acid Chemical class OC(=O)C1=CC=NC=C1 TWBYWOBDOCUKOW-UHFFFAOYSA-N 0.000 description 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 229940049920 malate Drugs 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N malic acid Chemical compound OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 125000005341 metaphosphate group Chemical group 0.000 description 1
- GRVDJDISBSALJP-UHFFFAOYSA-N methyloxidanyl Chemical group [O]C GRVDJDISBSALJP-UHFFFAOYSA-N 0.000 description 1
- YACKEPLHDIMKIO-UHFFFAOYSA-N methylphosphonic acid Chemical compound CP(O)(O)=O YACKEPLHDIMKIO-UHFFFAOYSA-N 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229960005181 morphine Drugs 0.000 description 1
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Natural products O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 1
- WUOSYUHCXLQPQJ-UHFFFAOYSA-N n-(3-chlorophenyl)-n-methylacetamide Chemical compound CC(=O)N(C)C1=CC=CC(Cl)=C1 WUOSYUHCXLQPQJ-UHFFFAOYSA-N 0.000 description 1
- SYSQUGFVNFXIIT-UHFFFAOYSA-N n-[4-(1,3-benzoxazol-2-yl)phenyl]-4-nitrobenzenesulfonamide Chemical class C1=CC([N+](=O)[O-])=CC=C1S(=O)(=O)NC1=CC=C(C=2OC3=CC=CC=C3N=2)C=C1 SYSQUGFVNFXIIT-UHFFFAOYSA-N 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- NIHNNTQXNPWCJQ-UHFFFAOYSA-N o-biphenylenemethane Natural products C1=CC=C2CC3=CC=CC=C3C2=C1 NIHNNTQXNPWCJQ-UHFFFAOYSA-N 0.000 description 1
- WWZKQHOCKIZLMA-UHFFFAOYSA-M octanoate Chemical compound CCCCCCCC([O-])=O WWZKQHOCKIZLMA-UHFFFAOYSA-M 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004043 oxo group Chemical group O=* 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 1
- WRAQQYDMVSCOTE-UHFFFAOYSA-N phenyl prop-2-enoate Chemical compound C=CC(=O)OC1=CC=CC=C1 WRAQQYDMVSCOTE-UHFFFAOYSA-N 0.000 description 1
- DYUMLJSJISTVPV-UHFFFAOYSA-N phenyl propanoate Chemical compound CCC(=O)OC1=CC=CC=C1 DYUMLJSJISTVPV-UHFFFAOYSA-N 0.000 description 1
- 229940049953 phenylacetate Drugs 0.000 description 1
- WLJVXDMOQOGPHL-UHFFFAOYSA-N phenylacetic acid Chemical compound OC(=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-UHFFFAOYSA-N 0.000 description 1
- 229950009215 phenylbutanoic acid Drugs 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- ACVYVLVWPXVTIT-UHFFFAOYSA-N phosphinic acid Chemical compound O[PH2]=O ACVYVLVWPXVTIT-UHFFFAOYSA-N 0.000 description 1
- 229940080469 phosphocellulose Drugs 0.000 description 1
- XNGIFLGASWRNHJ-UHFFFAOYSA-L phthalate(2-) Chemical compound [O-]C(=O)C1=CC=CC=C1C([O-])=O XNGIFLGASWRNHJ-UHFFFAOYSA-L 0.000 description 1
- 239000001259 polydextrose Substances 0.000 description 1
- 229940035035 polydextrose Drugs 0.000 description 1
- 235000013856 polydextrose Nutrition 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920005990 polystyrene resin Polymers 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- JWVCLYRUEFBMGU-UHFFFAOYSA-N quinazoline Chemical compound N1=CN=CC2=CC=CC=C21 JWVCLYRUEFBMGU-UHFFFAOYSA-N 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 229960004622 raloxifene Drugs 0.000 description 1
- GZUITABIAKMVPG-UHFFFAOYSA-N raloxifene Chemical compound C1=CC(O)=CC=C1C1=C(C(=O)C=2C=CC(OCCN3CCCCC3)=CC=2)C2=CC=C(O)C=C2S1 GZUITABIAKMVPG-UHFFFAOYSA-N 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 description 1
- 229960001860 salicylate Drugs 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 229940116351 sebacate Drugs 0.000 description 1
- CXMXRPHRNRROMY-UHFFFAOYSA-L sebacate(2-) Chemical compound [O-]C(=O)CCCCCCCCC([O-])=O CXMXRPHRNRROMY-UHFFFAOYSA-L 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 239000011973 solid acid Substances 0.000 description 1
- PJANXHGTPQOBST-UHFFFAOYSA-N stilbene Chemical compound C=1C=CC=CC=1C=CC1=CC=CC=C1 PJANXHGTPQOBST-UHFFFAOYSA-N 0.000 description 1
- 235000021286 stilbenes Nutrition 0.000 description 1
- TYFQFVWCELRYAO-UHFFFAOYSA-L suberate(2-) Chemical compound [O-]C(=O)CCCCCCC([O-])=O TYFQFVWCELRYAO-UHFFFAOYSA-L 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229940086735 succinate Drugs 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 125000000542 sulfonic acid group Chemical group 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- KKEYFWRCBNTPAC-UHFFFAOYSA-L terephthalate(2-) Chemical compound [O-]C(=O)C1=CC=C(C([O-])=O)C=C1 KKEYFWRCBNTPAC-UHFFFAOYSA-L 0.000 description 1
- PUGUQINMNYINPK-UHFFFAOYSA-N tert-butyl 4-(2-chloroacetyl)piperazine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCN(C(=O)CCl)CC1 PUGUQINMNYINPK-UHFFFAOYSA-N 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- FAQYAMRNWDIXMY-UHFFFAOYSA-N trichloroborane Chemical compound ClB(Cl)Cl FAQYAMRNWDIXMY-UHFFFAOYSA-N 0.000 description 1
- ITMCEJHCFYSIIV-UHFFFAOYSA-N triflic acid Chemical compound OS(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-N 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D333/56—Radicals substituted by oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Catalysts (AREA)
Description
經濟部中央標率局員工消費合作社印I A7 B7 五、發明説明(1) 本發明有醫藥化學範疇,並提供一種自二烷氧基乙醯苯 製備本并p塞吩化物之較佳方法。該方法於優越產率下大量 製備所期望之化合物。 先前U.S. 4,3 80,63 5中已描述了經由二烷氧基苯并嘍吩 中間物製備苯幷嘧吩之方法,其揭示供作本發明參考, 敎示α -(3-曱氧苯硫基)-4-甲氧乙醯苯於多磷酸(ppA)存在下 進行分子内環化。於約85Ό下於PPA中加熱乙醯苯起始物 質歷經約1小時,產生約3 : 1之兩異構物,6-甲氧_2_(4_甲 氧苯基)苯并[b]嘧吩及4-甲氧-2-(4-甲氧苯基)苯幷[b]嘆吩。 然而,當於製造規模下進行此反應時,異構苯幷嘍吩化物 析出,而產生無法於習用製造裝置中適當地攪拌之濃铜聚 液。
Guy等人,Synthesis, 222 (1980)已崎試於不同反應流程 圖中使用溶劑舒緩因漿液所致之問題。然而,當此項研究 應用於此情況下時,添加溶劑使起始乙醯苯之環化不完全 ,6-甲氧-3-(4-甲氧苯基)苯弁[b],塞吩之重排不完全,而大 幅增加反應時間。 因此,需要一種改良方法,其採用交替催化劑,以於適 當產率及可接受之反應時間下使二烷氧基乙醯苯衍生物轉 化成苯并嘍吩。 本發明提供一種利用陽離子交換樹脂製備苯幷H塞吩之方 法。此製法根據二烷氧基乙醯苯衍生物之分予内環化而產 生苯幷嘧吩。 因此,本發明提供一種製備式I化合物之方法 -4- 本紙張尺度適用中國國家標準(CNS ) Α4規格(2丨〇X297公釐) ΙΓ.------裝------訂----- (請先閱讀背面之注意事項再填寫本頁) 五、發明説明(2)
OR 其中該R基相同或相異,而表示〇1<6烷基 子父換樹脂存在下使式π化合物環化 其包括於陽
OR R0 Π 其中R基如前定義。 苯幷噻吩係爲合成拉洛西吩(ral〇xifene) _ 一種選擇性雌 激素受體調節劑或SERM之關鍵中間物。除了針對製備此中 間物提供改良方法外,本發明另外提供—種製備式⑴化合 物之改良方法 (請先閲讀背面之注##'項再填寫本頁) 裝· 項再填寫本 '?τ 經濟部中央標準局Λ工消費合作社印製 其中
N, R2 心及厌2個別爲CrC6烷基,或與鍵結彼基之氮一起形成六 氫吡啶基、四氫吡咯基、甲基四氫吡咯基、二甲基四氳吡 咯基、或己一亞胺基,或其醫藥上可接受之鹽或溶劑化物 5- 本/.vUe、適用中國國家標準(CNS ) A4規格(210χ 297公釐) ΦΜ 472053 經濟部中央標準局貝工消費合作社印製 A7 B7 五、發明説明(3) ;其包括於陽離子交換樹脂存在下,使式II之化合物環化
〇
II 其中R基相同或相異,而表示CrC6烷基。 許多起始物質及藉本發明方法製備之化合物皆另外描述 於1;.8.4,133,814及1;.3_4,380,635中,其揭示在此供作參考。 此文件中,所有溫度皆以攝氏度數陳述。所有量、比例 濃度、配額等皆以重量單位陳述,除非另有陳述,溶劑比 例外,係以體積單位表示。 本發明所用之"酸催化劑"一辭表示路易士酸或布忍斯特 酸。代表性路易士酸有氣化鋅、硪化鋅、氯化銘、及溴化 鋁。代表性布忍斯特酸包括無機酸,諸如硫酸及磷酸,叛 酸,諸如乙酸及三氟乙酸,磺酸,諸如甲烷磺酸、苯續酸 、1-審績酸、1-丁燒績酸、乙燒績酸、4-乙基苯績酸、1_己 烷磺酸、1,5-苯二磺酸、1-辛烷磺酸、梓腦磺酸、三氟甲境 磺酸、及對甲苯磺酸。或者,”酸催化劑”一辭包括陽離子 交換樹脂,亦可稱爲以樹脂爲底質之酸催化劑。此等陽離 子交換樹脂定義爲不可溶之酸性樹脂。該陽離子交換樹脂 包括但不限於位在聚葡萄糖上之陽離子交換劑,諸如例如 CM Sepharose (叛甲基 Sephadex)、SP Sephadex (續丙基 Sephadex)等,位於瓊脂糖上之陽離子交換劑,諸如例如cm Sepharose、S Sepharose等;位於纖維素上之陽離予交換劑 -6一 本认张.尺度適用中國國家標準(CNS ) A4規格(210X297公釐) II 裝 "訂 (請先聞讀背面之注意事項再填寫本頁} 472053 A7 ____ B7 五、發明説明(4 ) ,諸如例如CM維維素、磷酸纖維素、磺氧乙基纖維素等; 位於聚木乙稀上之陽離子交換劑’諸如例如經績化之聚苯 乙烯樹脂(一般爲樹脂上磺酸基總數相異),包括Amberlyst® XN-1010、Amberlyst® 15、Amberlite®、XE586® 等;經績化 之聚氟破化物樹脂’包括Nafion-H®樹脂;氧基纖維素;sp Trisacryl® 樹脂,諸如例如 SP Trisacryl Plus M® 及 SP Trisacryl Plus LS®,聚(甲基丙稀酿N-三[窥甲基]甲胺)樹脂 :等。 "鹵基"一辭意指氟基、氯基、溴基或破基。 "q-C6烷基”一辭表示具有一至六個碳原予之直鏈或分枝 鏈烷鏈。典型烷基包括曱基、乙基、正丙基、異丙基 、正丁基、異丁基 '第二丁基、第三丁基、正戊基 '異戊 基、正己基、2-甲基戊基等。"CrC6烷基,'一辭表示具有一 至四個碳原子之直鏈或分枝鏈燒鏈,包括甲基、乙基、正 丙基、異丙基、正丁基、第二丁基、異丁基及第三丁基。 經濟部中央標準局負工消費合作社印製 (請先閲讀背面之注意事項再填寫本頁) 適當活化醋基係技藝界已知。用以形成及去除保護基之 數種反應係描述於數種標準著述中,例如,有機化學中之 保護基,Plenum Press(儉敦及紐約,1973) ; Green,T.W.,有 機合成中之保護基,Wiley,(紐約,1981);及胜肽,第1册
Schrooder 及 Lubke,Academic Press (儉敦及紐:約;1965)。用 以非空間選擇性地去除羥基保護基-尤其是甲基—之方法 係技藝界已知。於6-及4·-位置上預先經甲氧基保護之式1:1 化合物可被選擇性地斷裂,產生具有4,-甲氧基之式in化合 物。用以使位在41-位置上之甲氧基斷裂之方法包括結合6_ -7- 本认张尺度適用中國國家標準(CNS ) A4規格(210X297公釐) ~ ~
472053 第861丨3989號專利申請案 中文說明書修正頁(88年2月) 五、發明説明(5 ) ' 4’-二甲氧基受質及去甲基化試劑,選自三溴化硼、三氯 化·、或三破化硼,或與A1Cl3及諸如£削之各種料試劑 結合。反應係於諸如氮之惰性氛圍下進行,每莫耳欲切除 之甲氧基使用一或多莫耳該試劑。 適於該脫保護反應纟溶劑有在整個脫甲基㈣中皆保持 惰性之溶劑或溶劑混合物。鹵化溶劑,諸如二氯甲烷、 1,2-二氣乙烷、及氣仿’或芳族溶劑’諸如苯或甲苯較佳 。此反應所採用之溫度應足以使之完成脫甲基反應。然而 ,使溫度保持於(TC,以使甲氧基斷裂選擇性達到最高 ’並避免形成不期望之副產物,尤其是過度脫甲基所產生 之產物6,4,-二羥基同質物。於較佳反應條件下,經選擇性 脫烷基之產物係於攪拌該反應約丨至24小時後形成。較佳變 數包括在-2(TC溫度下,於氮氛圍下,於二氣甲烷中,每一 莫耳6-,4’_二甲氧受質使用約15莫耳之量的三溴化硼’歷經 1至4小時。 本發明方法所用之起始物質可藉數種路徑得到,包栝 U.S. 4,133,814及U.S. 4,380,635所揭示。本發明所提供之式 化合物之製法示於以下流程圖I中: ----U------__ (請先閲讀背面之注意事項再填寫本頁) 訂 經濟部中央標準局員工消費合作社印策 __——1 本紙張尺度適用中國國家標準(CNS ). A4規格(210 X 297公釐) 472053 A7 B7 五、發明説明(6) 流程圖Γ
OR 環化
OR Kl 1 A]5樹脂,甲苯
OR lb (請先閱讀背面之注意事項再填寫本頁) 重排.甲貌續酸、甲苯、庚燒
OR
OR
ΟΙ 經濟部中央標準局員工消費合作社印製 整體反應過程包括第一個環化步驟及後續重排步驟。式I 化合物爲所期望之產物。第一個步驟中之環化反應係使用 各式各樣之酸催化劑進行,通常較後續重排反應快約50-100倍。本發明採用陽離子交換樹脂作爲酸催化劑。 -9- 本/..以;<尺度適β中國國家標準(CNS ) A4規格(210X297公釐) 472053 第S61 13989號專利申請案 中文說明書修正頁(S 8年2月) 五、發明説明(7 經濟部中央榡準局員工消費合作社印裝 _環化反應速率可藉著增加反應混合物中樹脂之用量而增 高。檢測採用A15樹脂作為陽離子交換樹脂_,催化劑充 填量對反應產率之影響。超過5至33毫升催化劑/克反:物 範圍以上時,對產率或對脫甲基程度無影響。然而,反應 速率與催化劑充填量成正比。 環化步驟可採用任何陽離子交換樹脂或陽離子交換樹脂 之组合物。進行本發明之較佳者為以聚苯乙烯為底質之陽 離子交換樹脂。以聚苯乙烯為底質之磺酸催化劑特佳。 陽離子交換樹脂可藉任何方式而輕易地自整體反應混合 物分離,包括但不限於過濾,任何回收之樹脂皆可再利用 。過濾可藉任何方式達成,包括使用Whatman濾紙,1〇〇篩 目網篩、5-2〇微米濾匣等。 該反應一般係於回流下共沸地移除水而進行。水對某些 反應中磺酸樹脂活性之影響已預先於A R Plt〇chelH,離子 父換催化及基質效應’ brochure,Rohm and Haas, Inc.,出版 ’ 1975中討論。亦參照g. Zundel ’使用多電解質薄膜之水 合及分子間相互作用紅外線檢視,Academic Press,纽約 1969,及 G. Zundel 等人,Physik. Chem., 59, 225,1968。 反應過程中可形成各式各樣之脫甲基副產物。以下流程 圖Π中提供4個不同脫曱基副產物之結構: -10- 本纸張尺度適用中國國家標準(CNS > A4規格(21〇X 297公釐〉 ^------- (請先閱讀背面之注意事項再填寫本頁) 訂 472053 第861 13989號專利申請案 A7 中文說明書修正頁(88年2月) B7 五、發明説明(
流程圖II
OCH
A
OH
OCH3 B CH30
C
(請先閲讀背面之注意事項再填寫本頁) 異構物A及B係自式la1化合物衍生,而異構物c及D係自式 I化合物衍生。典型反應混合物中異構物A:B:C:D比例約略 為1 .· 1:9··9。異構物通常藉HPLC確認。該異構物比例,及最 終產率係由動力控制環化反應決定。使用於甲苯中之陽離 子交換樹脂,於環化步驟中所得之異構物比例88 ; l2(I/Ia,) 較優於於環化步驟中使用多磷酸時之異構物比例75 _25。未 發現鄰位及對位異構物於此過程中之進一步平衡。 經濟部中央標準局員工消費合作社印裝 重排反應為熱力控制反應。該反應之平衡常數如下. K 100 ’而K2約7-9。使用陽離子交換樹脂及充作溶劑系统 之甲苯/庚烷’式I化合物於反應混合物中形成時則析出 以驅使反應完全。不期望之異構物—式Ib,化合物〜、 之重排 較所期望之異構物一式;[b化合物快3_5倍。 之選擇 進行本發明時所採用之溶劑,包括溶劑混合物及 可影響整體反應,包括反應產物及整體產率。溶,,各蜊 -11- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公瘦) 472053 A7 B7 經濟部中央標準局貝工消費合作社印製 五、發明説明(9 ) 一般爲極弱之鹼。此外,溶劑應不使樹脂之磺酸部分溶劑 化。用以進行本發明之較佳溶劑爲芳族溶劑,而脂族及氣 化溶劑皆得到合理結果。例示溶劑包括甲苯、庚烷、二甲 表、乳基苯、二甲氧乙燒、及四氣乙缔。進行本發明以甲 苯較佳。以添加甲烷磺酸之甲苯特佳。添加甲烷磺酸有利 於後續重排反應。需於甲苯中添加足量之甲烷磺酸以形成 個別MSA相。 庚燒爲另一種較佳溶劑,影響苯并嘧吩產品之結晶。該 結晶使彼之溶解度大幅降低,而驅動反應平衡。庚烷於平 衡前添加於反應混合物中最佳。 根據本發明,環化反應係於約50。(:至約11 〇°C溫度下進行 ’由約75°c至1 l〇°C較佳,而約80至約110Ό最佳。不論係 於回流或70°c下進行,環化反應之產率皆相同。然而,回 流遠較有利因爲反應速率快10_20倍。於反應期間使用較高 溫度並非所期望,因爲可能增加脱甲基副產物之濃度。 乙醯苯起始物質係於陽離子交換樹脂及甲苯存在下加熱 至少30分鐘,而由約60至180分鐘較佳。如目前所進行,乙 醯苯係於約11 〇°C下環化約3-5小時。於此初期加熱後,反 應冷却至由約50至90°C之溫度,而濾出陽離子交換樹脂。 若反應冷却至低於50°C,則有少量苯幷嘧吩析出,其爲環 化步驟期間重排量之函數。環化反應中一般有1 -7%重排。 該重排反應係於甲烷磺酸及甲苯反應混合物存在下進行 。此時可選擇性地再添加庚烷,但可能增加反應產率。於 反應期間添加庚燒後’因其對產率有負面影響,故不期望 -12- 尺度中國國家標準(CNS ) Α4規格(210X297公釐) '~~ (請先閲讀背面之注意事項再填寫本頁} 項再填ΐ 裳 -訂 472053 A7 B7 五、發明説明(10) 溫度自90。增至106〇。 可於重排反應終止時,另外添加適當溶劑或溶劑混合物 於反應混合物中,以使反應驟冷。適當溶劑之實例包括但 不限於異丙醇(^⑷等。此種溶劑添加降低產物溶解度,而 改善彼者純度。 整體過程可如"單錯"合成、分批、半連續、連續等方式 操作。熟習此技藝者已知此等操作模式間之差異,包括用 於特定目的之反應。例如,於半連續或連續操作中,該起 始物質及溶劑餵入固體酸樹脂之填充塔中。可藉蒸餾回收 並單離過量溶劑及產物。此外,該反應選擇性地於與水形 成共沸物之有機溶劑存在下進行,以於反應過程中藉共滞 蒸餾去除副產物。可使用之溶劑的實例包括芳族烴,諸如 表、甲苯、二甲苯等。 苯并嘍吩產物可使用標準萃取操作,藉著添加水、分層 、選擇性地再以有機溶劑萃取水層、結合有機層,並將結 合之有機層濃縮而單離》當起始物質爲甲氧衍生物時,所 需疋6-燒氧基化合物於濃縮溶劑中結晶,而4_烷氧基異構 物保持於溶液中。可過濾收集所需之6_烷氧基化合物。 經濟部中央榡率局貝工消費合作社印製 (請先閲讀背面之注意事項再填寫本頁) 於較佳之本發明環化方法中,起始物質爲α _(3_曱氧苯 凡基)·4-甲氧乙酿私’其於環化後加工時,產生6_甲氧_2_ (4_甲氧苯基)苯并[b]P塞吩。此物質隨之轉化成式m化合物 ,諸如例如6-羥基-2-(4-羥苯基)-3-[4-(2-胺乙氧)苄醯]苯幷 ΠΨ塞吩。6_烷氧基_2_(4_烷氧苯基)苯幷[b]嘧吩轉彳丨減式m化 口物之過程可根據u s· 4,38〇,635所提供之反應達成。 • — _ 1 3 _ 家標準(⑽)八4胁(训心97公 -- 472053 A7 B7 經濟部中央榇準局負工消費合作社印製 五、發明説明(η) 式III之化合物經常於酸加成型形式下用藥。如同一般有 機化學所常用者,該鹽係藉著根據本發明製備之化合物與 適當酸反應而簡便地形成。該鹽係於適當溫度下於向產率 下迅速地形成,而經常藉著合成最終步驟之適當酸洗而簡 單地單離。例如,可使用無機或有機酸形成鹽。 用以形成該鹽之典型無機酸包括鹽酸、氫溴酸、氫碘酸 、硝酸、硫酸、磷酸、次磷酸等。亦可使用自有機酸衍生 之鹽,諸如脂族單及二羧酸、經苯基取代之烷酸、羥基烷 酸及羥基烷二酸、芳族酸、脂族及芳族;酸。該醫藥上可 接受之鹽包括乙酸鹽、苯基乙酸鹽、三病。酸酸、丙烯酸 鹽、抗壞血酸鹽、苄酸鹽、氯基苄酸鹽、二硝基苄酸鹽、 羥基芊酸鹽、甲氧苄酸鹽、甲基芊酸鹽、“乙醯氧苄酸鹽 、莕-2-芊酸鹽、溴化物、異丁酸鹽、苯 丁酸鹽 ' 卢-幾 基丁酸鹽、丁炔-1,4-二酸鹽、己炔-1,4-J疫鹽、己酸鹽、 辛酸鹽、氯化物、苯丙烯酸鹽、檸檬酸.、甲酸鹽、反丁 烯二酸鹽、乙醇酸鹽、庚酸鹽、馬尿酸鹽、乳酸鹽、蘋果 酸鹽、順丁烯二酸鹽、羥基順丁烯二酸鹽、丙二酸鹽、為 桃酸鹽、甲磺酸鹽、菸酸鹽、異菸酸鹽、硝酸鹽、草酸鹽 、苯二曱酸鹽、對苯二甲酸鹽、磷酸鹽、磷酸單氫鹽、骑 酸二氫鹽、偏磷酸鹽、焦磷酸鹽、丙炔酸鹽、丙酸鹽 '苯 基丙酸鹽、水楊酸鹽、癸二酸鹽、琥珀酸鹽、辛二酸鹽、 硫酸鹽、硫酸氫鹽、焦硫酸鹽 '亞硫酸鹽、亞硫酸氫鹽、 磺酸鹽、苯磺酸鹽、對溴苯基磺酸鹽、氣苯磺酸鹽、乙燒> 磺酸鹽、2-羥乙烷磺酸鹽、甲烷磺酸鹽、茶-卜磺酸鹽、慕_ -14- 本ik尺及通用國國家標準(CNS)_A4規格(210X297公釐) (請先閱讀背面之注意事項再填寫本頁) ΙΦ 項再填2 裝- 、π [b] )胺基乙氧]苄醯] [b] 472053 五、發明説明(I2) 2-磺酸鹽、對甲苯磺酸鹽、苯二曱磺酸鹽、酒石酸鹽等。 較佳鹽係爲鹽酸鹽。 提供以下化合物以進一步説明本發明所揭示之整體方法; 6-遂基-2-(4_趣苯基)_3_[4_(2_二甲胺基乙氧)亨醯]苯幷肿塞 吩; 乙氧甲胺基乙氧)辛醯]_6_經基_2_(4_羥苯基)苯并 p塞吩; 3-[4-(2-乙氧異丙胺基乙氧汗醯]_6_經基_2_(4_羥苯基)苯并 [b]n塞吩; Η4·(2-二丁胺基乙氧)爷酿]_5邊基士(‘瘦苯基)苯幷叫嘧 吩; Η4_(2-(1-甲基丙基)甲胺基乙氧]爷醯]_ 基_2_(4_羥苯基) 苯幷[b]嘍吩; 6-起基-2-(4-趣苯基)-3-[4_[2_二(2_甲基汚 苯幷[b]嘧吩; 6_經基-2-(4-趣苯基)-3-[4-(2_四氫峨咯基·氧)爷醯]苯并 p塞吩; 6-羥基-2-(4-羥苯基)-3_[4·(2_六氫吡啶乙氧)苹醯]苯幷 吩; 6-趣基-2-(4-經苯基)-3-[4-(2•嗎福琳乙氧)卞驢]苯幷叫塞吩; 3-[4·(2-己二亞胺基乙氧)节醯]_6_幾基_2_(4_羥苯基)苯并
喧吩。 L J 以下實施例用以更詳細地説明本發明, —. 令赞月,而絕不限制其範 園。I·'習此技藝者確認可在不偏離本發明精神及範 ----;------tr (請先聞讀背面之注意事項-«-填寫本頁) [b]嘧 經濟部中央標率局員工消費合作衽印製 圍下地 _15_ 472053 第861 139S9號專利申請案 A7 中文說明書修正頁(88年2月) 37 五、發明説明(η) 進行各種改良。說明書中所述及之所有刊物及專利申請案 皆用以使熟習此技藝者明瞭本發明相關範圍。 實施例 所有實驗皆於乾燥氮正壓下進行。所有溶劑及試劑皆於 初得到時使用。該百分比通常係以重量計算(w/w);高效液 相層析(HPLC)溶劑除外,係以體積計算(v/v)。質子核磁共 振NMR)光譜及13C核磁共振光譜(13C NMR)係於300.135 MHz之 Bruker AC-300 FTNMR光譜儀或於 300 . 15MHz之 GE QE-300光譜儀得到。珍膠快速層析可如Still等人所述般地 使用矽膠60 (230-400篩目,E. Merck)進行。Still等人,有機 化學期刊,43, 2923(1978)。碳、氫、及氮之元素分析係於 Control Equipment Corporation 440 元素分析儀上測定。硫 之元素分析係於Brinkman比色元素分析儀上測定。溶點係 於開口玻璃毛細管中於Gallenkamp熱風浴溶點裝置或 Mettler FP62自動裝置中測定,而未經校正。使用Varian Instruments VG 70-SE或VG ZAB-3F質譜儀測定場解吸質譜 (FDMS)。高解析游離原子撞擊質譜(FABMS)係使用Varian Instruments VG ZAB-2SE 質譜儀得到。 經濟部中央標準局員工消費合作杜印製 (請先閲讀背面之注意事項再填寫本頁) 6-甲氧-2_(4-甲氧苯基)苯并[b]嘧吩可藉高效液相層析 (HPIX)測定,與藉公開合成路徑製備之此化合物白勺真實試 樣比較。參見例如美國專利第4,133,8 14號。 實施例1 環化: 將40g α -(3-甲氧苯硫基)-4-甲氧乙醯苯、4g無水 -16 - 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 472053 A7 B7 五、發明説明(14)
Amberlyst® 15 (A15)樹脂(R0hm & Haas 所售)、及 12〇 ml
Toluol (Drum Stock)添加於1公升三頸圓底燒瓶中,其裝有 回流冷凝器及汀-斯達克阱。該阱或是預先充填甲苯,或將 額外溶劑添加於反應器。混合物加熱至回流,於共沸去除 水下攪拌3-5小時。混合物冷却至5〇·7〇χ:。使用4.25cm Buchner漏斗濾出樹脂’並以20 mlf苯洗滌。記錄濾液總重 ,计算用以作爲淋洗液以將遽液移至5〇〇 mi重排燒瓶内所 需之甲苯體積。[淋洗液體積=(WT.-161.5)/0.866]。[註:此 淋洗液體積考慮在熱甲苯過濾期間之蒸發損失。] 重排: 經濟部中央標準局負工消費合作社印製 (請先閱讀背面之注意事項再填寫本頁) 將遽液移至裝有回流冷凝器之500 ml圓底燒瓶中。使用 滴液漏斗,於2-5分鐘内添加14g甲烷磺酸(MSA)。混合物以 3ml甲苯淋洗,於90°C下攪拌3-5小時。以5_20分鐘添加56ml 庚烷(Drum Stock)。混合物於90°C下攪拌1小時,於80χ:下 攪拌3-4小時。以5-20分鐘添加98ml異丙醇(ipA)(Drum Stock) ,隨後於約83°C下回流30分鐘。混合物於不快於每小時50 C之速率下冷却至〇°C。此物於0°C下擾拌至少1小時,過滤 ’以75ml 70/30(Toluol/IPA)洗滌兩次,於6〇°C下完全眞空下 乾燥。產率=77-80.4% ; 100%效能;0.1 %脱甲基;〇.1 %化合物 D ; 0.3% TRS。 實施例2 於領試工廠中進行以下反應。環化及重排皆於50加崙 Hastelloy C反應器中進行。除非另有陳述,否則反應條件 皆如同實施例1。 -17- 本认依尺度適用中國國家標準(cNS ) Μ規格(210X297公釐〉 472053 A7 B7 五、發明説明(15) 環化: π -(3-甲氧苯硫基)-4-甲氧基乙醯苯:14公斤 A15樹脂:1.4公斤 甲苯:42公升 環化回流時間:2.5小時 A15甲苯淋洗液:6公升 A15樹脂過滤溫度:60°C 重排: 經濟部中央標準局員工消費合作社印製 (請先聞讀背面之注意事項再填寫本頁) 1^18八:4.9公斤 MSA/甲苯淋洗液:1公升 庚烷前於90°C下之攪拌時間:3小時 庚烷後於90°C下之攪拌時間:1小時 庚烷後於80°C下之攪拌時間:3小時 庚烷:20公升 庚烷添加時間:20分鐘 IPA驟冷用量:34公升 IPA添加時間:17分鐘 添加IP A後之回流時間:3 0分鐘 冷却速率:每小時50°C 濾出產物前之最終溫度:〇°C 濾渣洗液:2X26公升之70/30曱苯/IPA 所得之結果爲: 產率77.5% 效能100.1% -18- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 472053 經濟部中央標準局負工消費合作社印製 A7 B7 五、發明説明(16) 相關物(rel subs) 0.21% 脱甲基0.08% 實施例3 此例所用之反應條件與實施例2相同,不同處爲以下變數 :使用50加崙玻璃内襯反應器以取代5〇加崙Hastdl〇y反應 器;添加庚烷前於90。(:之攪拌時間增爲4小時;而添加庚烷 後於80 C擾拌之時間增至4小時。所得結果如下: 產率:55% 效能:99.5% 相關物:0.30% 脱甲基:0.09% 實施例4 於領試工廠中進行以下反應: 環化及重排皆於50加崙玻璃内襯反應器中進行。除非另有 陳述’否則反應條件如實施例1所列。α -(3 -甲氧苯碎基) 4-甲氧乙醯氧用量増至16.5公斤,而所有其他進料皆依樣 放大。反應器中總體積隨而增加。反應混合物 田 y) 增至115轉每分鐘。所得結果有: 產率:79.6% 效能:100.6% 相關物:0.25% 脱甲基:0.08% -19- 本紙張尺度適用中國國家標準(CNS ) Α4規格(210X297公釐) I.I:------裝-- (請先閱讀背面之注意事項再填寫本頁) '?τ
Claims (1)
- 472053 第8 6 1 1 3 9 8 9號專利申請案 中文申請專利範圍修正本(90年6月)申請專利範圍 1. 一種製備式I化合物之方法其中R基相同或相異而表示Ci-C^烷基, 其包括: 於陽離子交換樹脂存在下使式II之二烷氧基化合物環化 (請先閲讀背面之注意事項再填寫本頁) R0OR 訂 經濟部中央標準局員工消費合作社印製 II 以製備式lb化合物lb 其中R基相同或相異,而表示C,-G烷基,及 本紙張尺度逋用中國國家梯準(CNS ) A4規格(210 X 297公釐) 472053 A8 __ __ D8 夂、申請專利範圍 重排式I b化合物。 1根據申請專利範圍第1項之方法,其中尺基係為甲基。 〇-根據申請專利範圍第1項之方法,其中該陽離子交換樹 脂係為以聚苯乙烯為底質之磺酸樹脂。 4. 根據中請專利範圍第1項之方法,其另外包括使該反應 混合物與甲烷磺酸於甲苯中接觸。 5. 根據申請專利範圍第4項之方法,其另外包括使該反應 混合物與庚燒接觸。 6. 根據申請專利範圍第5項之方法,其另外包括使該反應 混合物與異丙醇接觸。 7·根據申請專利範圍第1項之方法,其中該環化係於由約 7〇°C至約90°c之溫度下進行環化。 8.根據申請專利範圍第1項之方法,其中該方法係以分批 操作形式進行。 9·根據申請專利範圍第1項之方法,其中該方法係以連續 操作形式進行。 1(1 —種製備式III化合物之方法,經濟部中央樣隼局員工消費合作社印袈 (請先閱讀背面之注意事項再填寫本頁) -2- 472053 A8 B8 C8 D8 經濟部中央揉準局負工消費合作社印製 六、申請專利乾圍 其中: Ri及R2個別為基’或與鍵結彼之氮一起形成 六氫吡啶基、四氫吡咯基、甲基四氫吡咯基、二甲基四 氫吡咯基、或己二亞胺基,或其醫藥上可接受之鹽或溶 劑化物;其改良處包括: 於1%離子父換樹脂存在下使式π化合物環化其中R基相同或相異,而表示C「C6烷基,及重排式lb化 合物。 11.根據申請專利範圍第10項之方法,其中R係為甲基。 -3- 本紙張尺度逋用中國國家梯準(CNS ) A4说格(210X297公釐) ------------------訂---------- (請先閱讀背面之注意事項再填寫本頁)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US2669596P | 1996-09-25 | 1996-09-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
TW472053B true TW472053B (en) | 2002-01-11 |
Family
ID=21833302
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW086113989A TW472053B (en) | 1996-09-25 | 1997-12-26 | Process for the synthesis of benzothiophenes |
Country Status (31)
Country | Link |
---|---|
US (1) | US5977383A (zh) |
EP (1) | EP0832889B1 (zh) |
JP (1) | JP2001501208A (zh) |
KR (1) | KR20000048539A (zh) |
CN (1) | CN1088704C (zh) |
AR (1) | AR013321A1 (zh) |
AT (1) | ATE318805T1 (zh) |
AU (1) | AU718919B2 (zh) |
BR (1) | BR9712844A (zh) |
CA (1) | CA2266617A1 (zh) |
CO (1) | CO4900043A1 (zh) |
CZ (1) | CZ92899A3 (zh) |
DE (1) | DE69735339T2 (zh) |
EA (1) | EA001914B1 (zh) |
EG (1) | EG21037A (zh) |
ES (1) | ES2257761T3 (zh) |
HU (1) | HUP9904228A3 (zh) |
ID (1) | ID21349A (zh) |
IL (1) | IL129001A (zh) |
IN (1) | IN183239B (zh) |
MY (1) | MY118009A (zh) |
NO (1) | NO991193L (zh) |
NZ (1) | NZ334591A (zh) |
PE (1) | PE2699A1 (zh) |
PL (1) | PL332208A1 (zh) |
TR (1) | TR199900672T2 (zh) |
TW (1) | TW472053B (zh) |
UA (1) | UA62938C2 (zh) |
WO (1) | WO1998013363A1 (zh) |
YU (1) | YU15399A (zh) |
ZA (1) | ZA978372B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2002230409A1 (en) * | 2000-11-27 | 2002-06-03 | Eli Lilly And Company | Process for preparing 3-aryl-benzo(b)thiophenes |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1300575B (de) * | 1965-05-21 | 1969-08-07 | Bristol Myers Co | Benzo[b]thiophene |
US3394125A (en) * | 1965-10-23 | 1968-07-23 | Bristol Myers Co | 2-phenyl-3-tertiary-aminoalkoxy phenyl-and corresponding tertiaryaminoalkyl thio benzfurans substituted in the benzo nucleus with an alkoxy or tertiaryamino alkoxy or alkylthio group |
US4230862A (en) * | 1975-10-28 | 1980-10-28 | Eli Lilly And Company | Antifertility compounds |
US4133814A (en) * | 1975-10-28 | 1979-01-09 | Eli Lilly And Company | 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents |
AT364852B (de) * | 1977-11-05 | 1981-11-25 | Thomae Gmbh Dr K | Verfahren zur herstellung von kondensierten isothiazol-3(2h)-on-1,1-dioxiden und von deren salzen |
US4436748A (en) * | 1980-10-20 | 1984-03-13 | Hoechst-Roussel Pharmaceuticals Inc. | Benzo[b]thiophenes |
IL65379A0 (en) * | 1981-04-03 | 1982-05-31 | Lilly Co Eli | Process for preparing acylated benzothiophenes |
US4358593A (en) * | 1981-04-03 | 1982-11-09 | Eli Lilly And Company | Process for preparing 3-(4-aminoethoxybenzoyl)benzo[b]thiophenes |
US4380635A (en) * | 1981-04-03 | 1983-04-19 | Eli Lilly And Company | Synthesis of acylated benzothiophenes |
IL65378A (en) * | 1981-04-03 | 1986-02-28 | Lilly Co Eli | Process for preparing 3-(4-aminoethoxybenzoyl)benzo-(b)thiophenes |
AU555658B2 (en) * | 1981-04-03 | 1986-10-02 | Eli Lilly And Company | Benzothiophene compounds |
US4418068A (en) * | 1981-04-03 | 1983-11-29 | Eli Lilly And Company | Antiestrogenic and antiandrugenic benzothiophenes |
US4544746A (en) * | 1982-05-17 | 1985-10-01 | Ciba-Geigy Corporation | Process for preparing 2-anilinoacridone |
KR890701591A (ko) * | 1987-09-25 | 1989-12-21 | 베르너 발데그 | 4-(트리알킬벤질)-피페라지닐 화합물의 디아실 유도체 |
US5395842A (en) * | 1988-10-31 | 1995-03-07 | Endorecherche Inc. | Anti-estrogenic compounds and compositions |
DE4117512A1 (de) * | 1991-05-25 | 1992-11-26 | Schering Ag | 2-phenylbenzo(b)furane und -thiophene, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate |
JP3157882B2 (ja) * | 1991-11-15 | 2001-04-16 | 帝国臓器製薬株式会社 | 新規なベンゾチオフエン誘導体 |
DE4204969A1 (de) * | 1992-02-19 | 1993-08-26 | Basf Ag | Verfahren zur herstellung von benzo(b)thiophenen |
US6756388B1 (en) * | 1993-10-12 | 2004-06-29 | Pfizer Inc. | Benzothiophenes and related compounds as estrogen agonists |
US5523416A (en) * | 1994-07-22 | 1996-06-04 | Eli Lilly And Company | Process for preparing 3-(4-aminoethoxy-benzoyl) benzo (B)-thiophenes |
US5606075A (en) * | 1995-06-07 | 1997-02-25 | Eli Lilly And Company | Process for the synthesis of benzo[b]thiophenes |
US5606076A (en) * | 1995-06-07 | 1997-02-25 | Eli Lilly And Company | Process for the synthesis of benzo[b]thiophenes |
-
1997
- 1997-09-17 MY MYPI97004310A patent/MY118009A/en unknown
- 1997-09-17 PE PE1997000827A patent/PE2699A1/es not_active Application Discontinuation
- 1997-09-17 IN IN1714CA1997 patent/IN183239B/en unknown
- 1997-09-17 AR ARP970104264A patent/AR013321A1/es unknown
- 1997-09-17 ZA ZA978372A patent/ZA978372B/xx unknown
- 1997-09-18 EG EG96197A patent/EG21037A/xx active
- 1997-09-19 ID IDW990074A patent/ID21349A/id unknown
- 1997-09-19 BR BR9712844-9A patent/BR9712844A/pt not_active IP Right Cessation
- 1997-09-19 CZ CZ99928A patent/CZ92899A3/cs unknown
- 1997-09-19 NZ NZ334591A patent/NZ334591A/xx unknown
- 1997-09-19 PL PL97332208A patent/PL332208A1/xx unknown
- 1997-09-19 CN CN97198100A patent/CN1088704C/zh not_active Expired - Fee Related
- 1997-09-19 IL IL12900197A patent/IL129001A/xx not_active IP Right Cessation
- 1997-09-19 AU AU43561/97A patent/AU718919B2/en not_active Ceased
- 1997-09-19 KR KR1019990702454A patent/KR20000048539A/ko not_active Application Discontinuation
- 1997-09-19 WO PCT/US1997/016683 patent/WO1998013363A1/en not_active Application Discontinuation
- 1997-09-19 YU YU15399A patent/YU15399A/sh unknown
- 1997-09-19 JP JP10515741A patent/JP2001501208A/ja active Pending
- 1997-09-19 HU HU9904228A patent/HUP9904228A3/hu unknown
- 1997-09-19 UA UA99031657A patent/UA62938C2/uk unknown
- 1997-09-19 EA EA199900330A patent/EA001914B1/ru not_active IP Right Cessation
- 1997-09-19 CA CA002266617A patent/CA2266617A1/en not_active Abandoned
- 1997-09-19 TR TR1999/00672T patent/TR199900672T2/xx unknown
- 1997-09-22 ES ES97307377T patent/ES2257761T3/es not_active Expired - Lifetime
- 1997-09-22 DE DE69735339T patent/DE69735339T2/de not_active Expired - Lifetime
- 1997-09-22 AT AT97307377T patent/ATE318805T1/de not_active IP Right Cessation
- 1997-09-22 US US08/934,999 patent/US5977383A/en not_active Expired - Lifetime
- 1997-09-22 EP EP97307377A patent/EP0832889B1/en not_active Expired - Lifetime
- 1997-09-22 CO CO97055060A patent/CO4900043A1/es unknown
- 1997-12-26 TW TW086113989A patent/TW472053B/zh not_active IP Right Cessation
-
1999
- 1999-03-11 NO NO991193A patent/NO991193L/no not_active Application Discontinuation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6291685B1 (en) | Methods for the preparation of 4-hydroxybenzothiophene | |
SE520721C2 (sv) | Syntes av 3-(4-(2-aminoetoxi)bensoyl-2-aryl-6-hydroxibenso (b)tiofener | |
IL214178A (en) | Cleaning 1– [2– (2,4 – dimethylphenylsulfanyl) –phenyl] piperazine | |
US5808061A (en) | Intermediates and processes for preparing benzothiophene compounds | |
BRPI0713653A2 (pt) | processo para a preparação de sais de n-hidróxi-3-[4-[[[2-(2-metil-1h-indol-3-il)etil]amino]metil ]fenil]-2e-2propenamida | |
TW461888B (en) | Process for the synthesis of benzothiophenes | |
US5955608A (en) | Process for preparing benzoic acid derivative intermediates and benzothiophene pharmaceutical agents | |
TW472053B (en) | Process for the synthesis of benzothiophenes | |
TW298592B (zh) | ||
KR20010020378A (ko) | 벤조티오펜의 제조 방법 | |
IL143559A (en) | Process for the synthesis of benzothiophenes | |
MXPA99004323A (en) | Process for the synthesis of benzothiophenes | |
CA2215856A1 (en) | Dihydrobenzofluorene compounds, intermediates, compositions, and methods | |
US3160656A (en) | Benzocycloheptenones and derivatives | |
US7012153B2 (en) | Process for preparing benzoic acids | |
JPH10316674A (ja) | 安息香酸誘導体中間体およびベンゾチオフェン薬剤の製造方法 | |
WO2015156428A1 (ko) | 비결정성 랄록시펜 염산염의 신규 제조방법 및이에 사용되는 신규 중간체 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
GD4A | Issue of patent certificate for granted invention patent | ||
MM4A | Annulment or lapse of patent due to non-payment of fees |